Skip to main content

MFs registers total outflows of nearly Rs 52,000 crore in September; debt schemes hit the most

Across all scheme categories, liquid funds posted the highest outgo of Rs 65,951 crore during the review period, followed by nearly Rs 5,000 crore outflows each from money market schemes and ultra-short duration funds

September was a month of contrasts for fund houses as outflows in debt schemes rose significantly but slowed down in equity.

Total outflow from the debt category increased a whopping Rs 51,962 crore in September from Rs 3,907 crore in August, according to data from the Association of Mutual Funds in India's (AMFI) website.

Across all scheme categories, liquid funds posted the highest outgo of Rs 65,951 crore during the review period, followed by nearly Rs 5,000 crore outflows each from money market schemes and ultra-short duration funds.

“In September, companies withdraw their investments from liquid funds to meet their quarterly advance tax requirements and banks withdraw for meeting their capital adequacy norms,” NS Venkatesh, Chief Executive at AMFI, explained.

Normally, companies rush to redeem their investments from cash plans every quarter to meet their advance tax payment commitments. Companies pay advance tax in four instalments of 15 percent, 30 percent, 30 percent, and 25 percent on June 15, September 15, December 15, and March 15, respectively.

Credit risk funds registered outflows in September as well. This category registered outflow of Rs 539 crore, marginally lower than the Rs 554 crore outgo posted a month ago.



Equity schemes

Though equity-oriented mutual funds witnessed net outflows for the third month in a row, the pace has slowed down substantially from the previous month. During September, equity-oriented mutual funds witnessed a net outflow of Rs 734.4 crore, sharply lower than the Rs 4,000 crore outflow witnessed in August.

Among specific categories within equity schemes, multi-cap scheme witnessed the highest outflow of Rs 1,143 crore, followed by large-cap funds at Rs 576 crore.

Industry experts attributed the outflows to the recent Securities and Exchange Board of India (SEBI) circular on multi-cap funds.

“While the multi-cap category has been witnessing net outflows since June, SEBI’s recent guideline around the investment mandate for the category could have also contributed towards the net outflow this month,” said Himanshu Srivastava, Associate Director – Manager Research, Morningstar India.

SEBI on September 11 issued a circular which mandated multi-cap funds to allocate at least 25 percent of their portfolios to large-, mid- and smallcaps each by February 2021.

Some industry officials attributed the outflows from equity funds to panic redemptions when market fell. “The 7 percent fall in markets in the third week of September also would have led to reactionary redemptions from some mutual fund investors,” Gautam Kalia, Head Investment Solutions, Sharekhan by BNP Paribas, said.

In September, Sensex fell down over 1 percent.

Overall, net assets under management of the 42-player mutual fund industry fell to Rs 26.85 lakh crore in September from Rs 27.49 lakh crore a month ago.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more